NIH Launches Public-Private Partnership With 16 Drug Companies To Search For SARS-CoV-2 Treatments, Vaccines
STAT: NIH partners with 16 drug companies in hopes of accelerating Covid-19 treatments and vaccines
“The National Institutes of Health on Friday announced it would launch a sweeping public-private partnership between federal researchers and 16 pharmaceutical companies, aimed at coordinating and accelerating the development of Covid-19 treatments and vaccines. The partnership, to be known as Accelerating Covid-19 Therapeutic Interventions and Vaccines, or ACTIV, is meant to standardize research between the federally funded researchers and a broad array of drug companies, and prioritize research into drugs and vaccines that are having high near-term potential…” (Facher, 4/17).
Additional coverage of the partnership is available from Roll Call and Science.
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.